Anti-hyperostosis traditional Chinese medicine formula

A technology of bone hyperplasia and traditional Chinese medicine, which is applied in medical formulas, antipyretics, anti-inflammatory agents, etc., can solve the problems that anti-inflammatory and analgesic drugs cannot be eradicated, and achieve the effect of quick effect and high cure rate

Inactive Publication Date: 2017-03-15
孙明芳
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In order to solve the problem that anti-inflammatory and analgesic drugs cannot be eradicated in the treatment of hyperosteogeny by modern medicine, the present invention is an anti-osteogenous hyperplasia traditional Chinese medicine. , Caulis Spatholobus, Cistanche, Panax notoginseng, Frankincense, Myrrh, Chuanxiong;

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] Weigh 60 grams of Rehmannia glutinosa, 60 grams of drynariae, 60 grams of sunburberry, 60 grams of Caulis Spatholobus, 60 grams of Cistanche, 30 grams of Sanqi, 30 grams of frankincense, 30 grams of myrrh, and 30 grams of Chuanxiong. The above herbs are ground into fine powder, and the honey is refined into pills, each weighing 6 grams.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An anti-hyperostosis traditional Chinese medicine formula includes: 10-18% of radix rehmanniae preparata, 10-18% of drynaria fortunei, 10-18% of honey-fried semen strychni, 10-18% of caulis spatholobi, 10-18% of herba cistanche, 5-9% of panax notoginseng, 5-9% of frankincense, 5-9% of myrrh, and 5-9% of rhizoma chuanxiong. The traditional Chinese medicine is prepared by weighing the nine medicines hereinabove, and grinding the medicines together into fine powders, and processing the fine powders with honey into pills, each pill being 6 g in weight. The traditional Chinese medicine can solve a problem that the hyperostosis cannot be cured fundamentally with an anti-inflammatory and analgesic drug in therapy according to modern medicine. The medicine is suitable for treating the hyperostosis.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine prescription for anti-osteogeny. [0002] technical background [0003] Osteoarthritis is due to the degeneration and degeneration of cartilage, intervertebral discs, ligaments and other soft tissues that make up the joint, bone spurs form on the edge of the joint, hypertrophy of the synovium and other changes, resulting in bone destruction and joint deformation. Modern medicine usually uses Anti-inflammatory analgesic drugs cannot be eradicated. Contents of the invention [0004] In order to solve the problem that anti-inflammatory and analgesic drugs cannot be eradicated in the treatment of hyperosteogeny by modern medicine, the present invention is an anti-osteogenous hyperplasia traditional Chinese medicine. , Caulis Spatholobus, Cistanche, Panax notoginseng, Frankincense, Myrrh, Chuanxiong; [0005] The component ratio ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/804A61K9/20A61P19/08A61P29/00
Inventor 孙明芳
Owner 孙明芳
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products